Medical Research
Phare Bio Inc
BOSTON, MA
Total revenue
$2.1M
Total expenses
$1.5M
Net assets
$2.5M
Grants received
$4.8M
15 grants
EIN
851085804
Tax year
2023
Mission
Phare bio uses ai/deep learning to develop novel antibiotics to tackle antimicrobial resistance.
Financials
FY 2023
Revenue
Expenses
People
8 listed
AKHILA KOSARAJU
CEO & PRESIDENT
$549K
40 hrs/wk
STEVE ELLIS
DIRECTOR
—
1 hrs/wk
JAMES COLLINS
DIRECTOR
—
1 hrs/wk
JOSE-CARLOS GUTTIEREZ-RAMOS
DIRECTOR
—
1 hrs/wk
ROBERT PLENGE
DIRECTOR
—
1 hrs/wk
SUSAN URAHN
DIRECTOR
—
1 hrs/wk
WILLIAM FOSTER
CHAIR & TREASURER
—
1 hrs/wk
CLAIRE NISHIOKA ROBINSON
SENIOR DIRECTOR, BUSINESS STRATEGIES
$160K
40 hrs/wk
Grants received
Showing 15 of 15
Funded by
$4.8M from 6 funders · 15 grants · 2020–2024
$2M · 4 grants · 2020–2023
$1.8M · 5 grants · 2020–2023
$600K · 3 grants · 2022–2024
$200K · 1 grant · 2022
$133K · 1 grant · 2023
$67K · 1 grant · 2023